INTRODUCTION
Chronic inflammation triggered by microbiota-dependent innate and adaptive immune responses is the main driving force in the development of inflammatory bowel disease. 1 The role of NF-kB as a crucial factor contributing to the initiation and maintenance of chronic inflammation has been wellknown. 2, 3 The five NF-kB family members, p65 (RelA), RelB, c-Rel, p105/p50 (NF-kB1), and p100/p52 (NF-kB1) are actively involved in central cellular processes such as proliferation, differentiation, and survival. 4 In unstimulated cells, NF-kB proteins pre-exist as inactive dimers associated with one of the inhibitory IkB proteins such as IkBa, IkBb, and IkBe. 5 Stimulation of cells with appropriate stimuli leads to translocation of active NF-kB dimers into the nucleus. 6 The signaling to NF-kB is generally considered to occur through either degradation of cytoplasmic IkB proteins (classical pathway) or through processing of p100 to form p52 (alternative pathway). The third signaling cascade, so-called p105 pathway, shares some similarities with classical NF-kB pathway and is responsible for rapid degradation of p105 and release of active NF-kB subunits. 7 During intestinal inflammation, NF-kB proteins regulate induction of the transcription of genes encoding various proinflammatory cytokines, chemokines, and adhesions molecules thus augmenting chronic inflammatory responses. 8, 9 The NF-kB family member c-Rel has an important role in the innate and adaptive immunity by regulating the function of antigen presenting cells (APCs) and lymphocytes. [10] [11] [12] Innate lymphoid cells (ILCs) are an emerging immune cell population involved in the mucosal tissue homeostasis and onset of inflammation in the intestine. 13, 14 Mirroring the complexity of the distinct T-helper (Th) subpopulations that secrete characteristic signature cytokines, an expanding family of ILCs that are capable of producing many Th cell-associated cytokines has been recently described. 15, 16 ILCs are heterogeneous consisting of at least three subpopulations, ILC1 secreting interferon-g (IFN-g), ILC2 expressing GATA-3 and producing Th2 cellrelated cytokines and the ILC3 population which expresses RORgt and secretes Th17-associated cytokines interleukin-17 (IL-17) and IL-22. 17 Recently, several reports demonstrated an essential role for ILCs during development of gut inflammation in mouse models of colitis. 13, 18 Mice deficient for T and B cells injected with anti-CD40 monoclonal antibody (mAb) developed colitis and rapid weight loss. 19 Depletion of Thy1 þ ILCs in rag1 À / À mice was shown to completely abrogate anti-CD40 mAb-induced gut inflammation demonstrating a key role for this immune cell population in mediating intestinal immunopathology in the absence of T cells. 13 In contrast to the well-defined function of c-Rel in T-cellmediated immunity, the role of this transcription factor in promoting anti-CD40-induced innate intestinal inflammation has not been addressed yet. We here described that the absence of c-Rel protects rag1 À / À mice from innate cell-driven colitis. Moreover, we provide evidence that CD40 stimulation leads to activation of c-Rel in dendritic cells (DCs), which in turn triggers Thy1
þ ILCs to produce IFN-g and promote intestinal inflammation.
RESULTS

CD40 ligation induces c-Rel activation in DCs
Members of NF-kB family of transcription factors have a central role in the initiation of chronic inflammation, however their impact on anti-CD40-induced innate colitis is not known yet. To analyze the functional role of c-Rel in promoting anti-CD40-induced intestinal inflammation, we first examined whether CD40L and anti-CD40 stimulation of DCs led to activation of this transcription factor. So far, CD40 has been reported to strongly activate the processing of NF-kB2 p100 to p52, thus promoting the nuclear translocation of p52-RelB dimers in primary B cells. 20, 21 In accordance with previous data, the electrophoretic mobility shift assay (EMSA) experiments clearly demonstrated that both, CD40L and anti-CD40 strongly activated NF-kB in bone marrow DCs (BMDCs; Figure 1a) . However, not only activation of the alternative NF-kB pathway but also CD40-induced nuclear translocation of c-Rel was observed after CD40L or anti-CD40 stimulation for 2 h (Figure 1b , data not shown). To quantify transcriptional (Figure 1e) . LPSinduced cell surface expression of CD40 was described to be diminished in p50 À / À rel À / À DCs compared with WT cells.
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As downregulation of CD40 in rel À / À cells might be responsible for reduced cytokine secretion, WT and c-Rel-deficient DCs were stimulated with LPS, CD40L, and anti-CD40, and To examine if c-Rel is required for the development of anti-CD40-induced colitis, we crossed c-Rel-deficient mice with rag1 À / À animals and treated both rag1 À / À and rag1 À / À rel À / À mice with anti-CD40 mAb. rag1 À / À mice injected intraperitonealy (IP) with 200 mg of anti-CD40 mAb, clone FGK45, have been shown to develop histological signs of colitis within 7 days. 19 Furthermore, depletion of Thy1 þ ILCs protected rag1 À / À animals from anti-CD40-induced intestinal inflammation. 13 To determine whether these findings are specific for FGK45 or apply also to other agonistic anti-CD40 Abs, we injected clone 1C10, which we used for in vitro stimulation of BMDCs ( Figure 1 ). Similar to FGK45-mediated colitis, IP injection of 100 mg of 1C10 led to development of colitis in rag1 À / À mice with macroscopic and histological signs of colon pathology. While IP administration of 1C10 to rag1 À / À animals triggered potent systemic and gut inflammation with loss of weight, increased amounts of serum cytokine concentrations, gut edema, epithelial hyperplasia, and leukocyte infiltration into colonic lamina propria, rag1
mice developed neither signs of intestinal inflammation and nor systemic immunopathology ( Figure 2a -c, data not shown). Furthermore, analysis of IL-12 and IL-23 gene expression upon induction of anti-CD40-mediated colitis showed that colonic tissue from rag1 À / À mice expressed significantly more IL-12 p40, IL-12 p35, and IL-23 p19 messenger RNA than colonic rag1 Figure 3a) . Similarly, secretion of colonic IL-23 after anti-CD40 treatment was much stronger in rag1
On the other hand, we found no differences in the colonic messenger RNA expression of IL-23R between rag1
À / À and rag1 (Figure 3b and c). Taken together, our results indicate that the transcription factor c-Rel has a crucial role in the development of anti-CD40-induced innate colitis but seems not to impact on expression of IL-23R in colonic Thy1 þ ILCs, which have been shown to be the only IL-23R þ cell population in the colon of rag1 À / À mice. Cytokine secretion by colonic lamina propria cells from anti-CD40-treated mice was examined after overnight culture. Whereas colonic lamina propria cells from healthy mice secreted only marginal amounts of proinflammatory cytokines, CD40-stimulated rag1 À / À mice strongly elevated IFN-g and tumour-necrosis factor-a but not IL-17A production in the colon. In contrast, only moderate increase in secretion of inflammatory cytokines was observed in anti-CD40 mAbtreated rag1
þ ILCs are colitogenic cells following injection of anti-CD40 mAb into rag2 mice. 18 To test this, rag1 À / À mice were injected IP with anti-CD40 mAb together with IFN-g blocking mAb. Indeed, blockade of IFN-g secretion led to significant reduction of weight loss and less pronounced intestinal pathology confirming that this cytokine has a colitis-promoting role after CD40 stimulation (Figure 4d and e) . Accordingly, depletion of Thy1 þ cells ameliorated colitis development in anti-CD40-treated rag1
À / À mice as previously shown (Figure 5a ).
Following disease induction by the agonistic anti-CD40 Ab, Thy1.2 þ cells were found to be the major source of IFN-g in the colonic lamina propria. Remarkably, while the onset of colitis in rag1 À / À mice correlated with the strong induction of IFN-g production by Thy1.2 þ cells, anti-CD40 treatment of rag1 À / À rel À / À induced only moderately elevated IFN-g levels as compared with untreated mice (Figure 5b and c) . Colonic inflammation in rag1 À / À mice correlated with elevated ILC3s, all of them expressing IFN-g, 25 it is difficult to exactly define the expanded subset of IFN-g-expressing Thy1.2 þ cells based on the expression of NK1.1 and NKp46. However, because the majority of IFN-g þ Thy1.2 þ cells also expressed CD127, which is found on all ILC subpopulations apart from conventional NK cells, our data suggest that colitogenic IFNg þ Thy1.2 þ cell population might predominantly consists of ILC subsets (Figure 5e) . Notably, IL-17A production was not induced within colonic Thy1.2 þ ILCs after anti-CD40 mAb challenge (Supplementary Figure S2a) , which is in line with a previous study describing an IL-17A-independent pathogenic role for ILCs in this colitis model. 13 Transfer of WT DCs induces colitis and promotes IFN-c expression by colonic Thy1.2
As IP administration of anti-CD40 Ab did not lead to induction of CD40 on Thy1.2 þ ILCs in rag1 À / À mice but strongly induced nuclear c-Rel activity in DCs (Figures 6a and 1b) , we assumed an indirect regulation of colitogenic Thy1.2 þ cells by c-Rel derived from APCs. Further, total numbers of Thy1.2 þ ILCs in the colon of naive rag1 À / À and rag1 À / À rel À / À mice were similar (Supplementary Figure S2b) . To demonstrate the causative link between c-Rel expression in APCs and development of intestinal inflammation, LPS-stimulated WT or rel À / À BMDCs were injected IP into the rag1
rel À / À mice prior to the treatment of these animals with anti-CD40 mAb. In contrast to rel À / À BMDCs, the transfer of WT BMDCs into rag1 À / À rel À / À mice was sufficient to induce intestinal inflammation, loss of body weight, and an increase in IFN-g expression by colonic Thy1.2 þ cells (Figure 6b-e) . These results strongly suggest that c-Rel expression in inflammatory DCs is responsible for development of anti-CD40-mediated intestinal inflammation.
Finally, we performed immunohistochemical staining of c-Rel expression in the inflamed gut of Crohn's disease patients. Significantly increased expression of c-Rel was observed in infiltrating inflammatory cells in patients with Crohn's disease patients as compared with the low expression of this transcription factor in the healthy colon. In particular, we found Figure S3) .
DISCUSSION
The underlying mechanisms linking CD40 stimulation of APCs with ILC-driven innate intestinal inflammation still remain obscure. In this study, we set out to determine whether the expression of the NF-kB member c-Rel in DCs contributes to the development of anti-CD40-induced colitis. Recently, the role for c-Rel in the development of intestinal inflammation was studied in the chronic model of Helicobacter hepaticusmediated innate colitis as well as in the T-cell transfer model of colitis. 26 Consistent with previous observation showing the importance of c-Rel in inducing intestinal inflammation, we demonstrate that this transcription factor is also involved in the development of anti-CD40-induced colitis. Here, CD40 stimulation of myeloid cells triggers effector cytokine production by colitogenic Thy1 þ ILCs of lymphoid origin thus crucially contributing to the inflammatory loop leading to immunopathology in the gut. 13 ILCs are a newly described immune cell population, which have been shown to regulate homeostasis and inflammation at mucosal sites. 17 The experiments presented here show that the NF-kB member c-Rel is activated by CD40 ligation. As a consequence, the secretion of IL-12 and IL-23 is induced in colonic APCs, suggesting that the pathogenic effects of c-Rel are probably mediated by IL-12/IL-23-controlled production of proinflammatory cytokines by colitogenic Thy1 þ ILCs. Indeed, during the course of anti-CD40 colitis, c-Rel regulated indirectly production of IFN-g by Thy1 þ ILCs. While rag1 À / À animals developed colonic wasting disease, rag1
rel À / À mice were largely protected from anti-CD40-induced colitis and transfer of WT DCs was capable of inducing intestinal inflammation and IFN-g production in rag1
There is considerable controversy with respect to the colitogenic ILC populations in murine and human ILCs. Although cytokines such as IL-17A and tumour-necrosis factor-a might have an important role, accumulating evidences point to the crucial role for IFN-g þ ILCs in promoting gut immunopathogenesis in both species. Novel studies suggest that IFN-g þ ILC subpopulation with colitogenic functions also accumulate in the inflamed intestine of inflammatory bowel disease patients. 27, 28 Notably, we were surprised to observe the lack of involvement of colonic IL-17A in development of anti-CD40-mediated-colitis in rag1 À / À mice, which is in contrary to Helicobacter hepaticus-induced intestinal inflammation. 13 In agreement with a previous study showing that ILC-derived IL-17A was dispensable for anti-CD40-induced innate colitis 13 and based on our observations that the expression of colonic IL-17A was not significantly changed after anti-CD40 treatment of rag1 À / À mice, we suggest that the predominant source of this cytokine are colonic Th17 cells rather than ILCs. Together, the role of IL-17A in intestinal inflammation remains controversial with both, inflammatory and protective effects. 29, 30 In summary, our data provide insights into the mechanisms linking CD40-mediated signaling specificities in DCs and Thy1 þ cell-dependent intestinal inflammation in mice. We identified c-Rel as a crucial factor that controls inflammatory functions of colonic Thy1 þ ILCs. Since the transfer of WT BMDCs into rag1 À / À rel À / À mice induced colonic inflammation and enhanced the production of IFN-g by Thy1 þ ILCs, we propose an indirect mechanism of c-Rel-dependent inflammation in the absence of T lymphocytes.
METHODS
Human samples. Inflamed mucosa from colon of patients with Crohn's disease was obtained after intestinal surgery at the Charité University Hospital in Berlin. Non-inflamed colonic samples referred to as ''healthy control'' were collected after intestinal resection of colorectal cancer, whereby the proximal colon was considered unaffected. All tissue samples were collected after subjects provided informed consent. This study was approved by the local ethics committee of the Charité Universitätsmedizin Berlin, Germany. Immunohistochemistry analysis was carried out on paraffinembedded colonic tissue as described previously. 31 The following primary antibodies were used for the staining: polyclonal rabbit anti-cRel (Cell Signaling Technology, Danvers, MA), monoclonal mouse anti-CD68, and polyclonal rabbit anti-CD11c (Thermo Scientific, Waltham, MA).
Experimental animals. Mice were kept in specific pathogen-free (SPF) facilities at Max Planck Institute for Infection Biology, Berlin, Germany and Philipps University of Marburg, Marburg, Germany. C57BL/6 mice were purchased from Charles River Laboratories. rel À / À mice were obtained from Hsiou-Chi Liou (Cornell University, NY). rel À / À , rag1 À / À and rag1 À / À rel À / À mice were bred on a C57BL/6 background. All animal studies were conducted according to the German animal protection law.
Induction of colitis and histology. Anti-CD40 colitis was induced by IP injecting 100 mg of monoclonal anti-CD40 Ab, clone 1C10 (rat IgG2a). The hybridoma producing anti-CD40 Ab, clone 1C10 was obtained from Manuela Staeber, (Max Planck Institute for Infection Biology, Berlin, Germany). The anti-CD40 Ab was purified using a protein G Sepharose 4 fast Flow column (GE Healthcare, Freiburg, Germany). Rat IgG2a isotype control (clone R35-95, BD Bioscience, Heidelberg, Germany) and phosphate buffered saline injections were used for treatment of age-and sex-matched control mice. Animals were monitored daily throughout the course of the experiment for body weight loss and disease activity. In some experiments, 3 mg of IFN-g blocking mAb (clone XMG1.2) were co-administered together with 1C10 Ab. Thy1.2 þ cells were depleted by injecting 250 mg of antiThy1 Ab (clone 30H12) at days À 1, þ 1 and þ 3 during the induction of anti-CD40-mediated colitis in rag1 À / À mice. Histological scores were determined using formalin-fixed tissue sections from proximal colons stained with Hematoxylin and eosin. Colons were prepared for histology 7 days after induction of colitis. The inflammation scoring was performed based on a combination of colonic tissue damage and infiltration of inflammatory cells.
Cytokine secretion by colon cultures and ELISA. Colon pieces of 1 cm length were cultured in RPMI 1640 medium containing 10% FCS. Media were supplemented with penicillin/streptomycin (PAA) and gentamycin (50 mg ml À 1 ). The supernatants were harvested after 24 h and cytokine concentrations were measured using ELISA. IL-17A and tumour-necrosis factor-a were detected using OptEIA ELISA kits (BD Bioscience). IL-12 p40 ELISA kit was purchased by eBioscience (Frankfurt, Germany). For detection of IL-23, Ready-Set-Go! ELISA kit (eBioscience) was used with p40 and p19 antibodies ensuring specific measurement of this cytokine.
Generation and transfer of BMDCs. BMDCs were generated from BM of 8-to 12-week-old C57BL/6 and rel À / À mice. BM cells (2 Â 10 6 ) were seeded on Petri dishes and cultured for 1 week in 10 ml of RPMI medium supplemented with 10% of Â 6310-derived granulocytecolony-stimulating factor. Medium conditioned with Â 6310 was replaced on days 3 and 5. On day 7, non-adherent cells were collected and subjected to stimulation with LPS (1 mg ml À 1 ), CD40L (1 mg ml À 1 ), and anti-CD40 (10 mg ml À 1 ). 1C10 anti-CD40 mAb was generated at Max Planck Institute for Infection Biology, Berlin and used for all in vitro studies to cross-link CD40 on BMDCs.
For transfer experiments, WT and rel À / À BMDCs were stimulated with LPS (1 mg ml À 1 ) for 24 h and subsequently, 6 h before the induction of anti-CD40 colitis, 5 Â 10 6 LPS-treated BMDCs were IP injected into rag1 Western blot analysis. For immunoblotting, BMDCs were stimulated for 2 h and nuclear and cytoplasmic extract from BMDCs were prepared by lysing the cells in buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 20 mM NaF, 100 mM Na 3 VO 4 , complete protease inhibitor (Roche Molecular Biochemicals, Mannheim, Germany)). After addition of 0.25% of Nonidet-P40 and incubation for 20 min, cells were centrifuged as supernatants were collected and used as cytoplasmic extracts. For generation of nuclear extracts, pellets were resuspended in the buffer B (10 mM HEPES, pH 7.9, 420 mM NaCl, 0.2 mM EDTA 1.5 mM MgCl 2 , 10 mM KCl, 20 mM NaF, 100 mM Na 3 VO 4 , complete protease inhibitor (Roche Molecular Biochemicals) and incubated for 30 min. After centrifugation (10,000 r.p.m., 10 min) to remove cell debris, supernatants containing nuclear proteins were collected and protein concentration was determined. To analyze the nuclear translocation of c-Rel, nitrocellulose membranes were incubated with antibodies against c-Rel, Lamin B (both from Santa Cruz Biotechnology, Heidelberg, Germany), and a-tubulin (Sigma-Aldrich).
EMSA. EMSA assay was performed using chemiluminescent EMSA kit (Thermo Fisher Scientific, Waltham, MA) according to manufacturer instructions. In brief, binding reactions were prepared in 20 ml reaction volume containing 10 mg of nuclear extracts from stimulated BMDCs and NF-kB consensus sequence 5 0 -GCCTGGGAAAGTCCCCT-CAACT-biotin-3 0 at room temperature for 20 min. Protein-DNA complexes were resolved on a 4% native polyacrylamid gel and transferred to a positive nylon membrane. After ultraviolet-crosslinking, the samples were treated with streptavidine-horseradish peroxidase conjugate and incubated with substrate solution.
ELISA-based DNA binding assay. Nuclear extract were prepared as described for immunoblotting and EMSA, and ELISA-based assay for measurement of NF-kB binding activity to the immobilized consensus sequence 5 0 -GGGACTTTCC-3 0 was performed using a Trans AM commercial kit (Active Motif, La Hulpe, Belgium). To obtain higher sensitivity, anti-c-Rel Ab sc-70 Â (Santa Cruz Biotechnology) was used.
Chromatin immunoprecipitation. For chromatin immunoprecipitation experiments, BMDCs were generated from C57BL/6 and stimulated with a-CD40 mAb (10 mg ml À 1 , 1C10) for 2 h. A total of 1 Â 10 6 BMDCs were fixed with 1% formaldehyde, DNA was then fragmented by sonication and immunoprecipitation was performed overnight at 4 1C with anti-mouse c-Rel IgG Ab (sc-70X, Santa Cruz Biotechnology) or control rabbit IgG. To reverse the crosslinking, the digestion with Proteinase K (20 mg ml À 1 ) was performed overnight. To determine the c-Rel binding to the k1 site of p19 promotor, the quantitative real-time PCR was performed with the following primer set: k1-forward, 5 0 -CCCGACCTAGGCCTCTAGC-3 0 ; k1-reverse, Statistical analysis. All data analyses were performed using Student's t-test and GraphPad Prism 5 software. P-values of Po0.05 were considered significant. In all experiments, unpaired Student's t-test P-values were used (***Po0.001, **P ¼ 0.001-0.01, *P ¼ 0.01-0.05).
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